These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

566 related items for PubMed ID: 21292109

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Hydroxychloroquine and chloroquine retinopathy: a systematic review evaluating the multifocal electroretinogram as a screening test.
    Tsang AC, Ahmadi Pirshahid S, Virgili G, Gottlieb CC, Hamilton J, Coupland SG.
    Ophthalmology; 2015 Jun; 122(6):1239-1251.e4. PubMed ID: 25824328
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Disparity between visual fields and optical coherence tomography in hydroxychloroquine retinopathy.
    Marmor MF, Melles RB.
    Ophthalmology; 2014 Jun; 121(6):1257-62. PubMed ID: 24439759
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy.
    Michaelides M, Stover NB, Francis PJ, Weleber RG.
    Arch Ophthalmol; 2011 Jan; 129(1):30-9. PubMed ID: 21220626
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Current screening practice in patients under long-term hydroxychloroquine medication in Taiwan: A nationwide population-based cohort study.
    Yen CY, Lee PH, Yen JC, Chen CC, Hu HY, Tseng PC.
    Medicine (Baltimore); 2019 Apr; 98(14):e15122. PubMed ID: 30946384
    [Abstract] [Full Text] [Related]

  • 11. Current opinion on hydroxychloroquine-related retinal toxicity screening: where do we stand now?
    Aduriz-Lorenzo PM, Aduriz-Llaneza P, Araiz-Iribarren J, Khamashta MA.
    Lupus; 2020 Jun; 29(7):671-675. PubMed ID: 32316844
    [Abstract] [Full Text] [Related]

  • 12. Comparison of different screening methods for chloroquine/hydroxychloroquine retinopathy: multifocal electroretinography, color vision, perimetry, ophthalmoscopy, and fluorescein angiography.
    Missner S, Kellner U.
    Graefes Arch Clin Exp Ophthalmol; 2012 Mar; 250(3):319-25. PubMed ID: 22215255
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of screening procedures in hydroxychloroquine toxicity.
    Marmor MF.
    Arch Ophthalmol; 2012 Apr; 130(4):461-9. PubMed ID: 22159170
    [Abstract] [Full Text] [Related]

  • 16. The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy.
    Melles RB, Marmor MF.
    JAMA Ophthalmol; 2014 Dec; 132(12):1453-60. PubMed ID: 25275721
    [Abstract] [Full Text] [Related]

  • 17. [Critical review of the new recommendations on screening for hydroxychloroquine retinopathy].
    Costedoat-Chalumeau N, Ingster-Moati I, Leroux G, Fardeau C, Benveniste O, Simon C, Bodaghi B, Piette JC.
    Rev Med Interne; 2012 May; 33(5):265-7. PubMed ID: 22088232
    [Abstract] [Full Text] [Related]

  • 18. [Update on recommendations for screening for hydroxychloroquine retinopathy].
    Couturier A, Giocanti-Aurégan A, Dupas B, Girmens JF, Le Mer Y, Massamba N, Barreau E, Audo I, DHU Vision, and Handicap task force rétine.
    J Fr Ophtalmol; 2017 Nov; 40(9):793-800. PubMed ID: 29054477
    [Abstract] [Full Text] [Related]

  • 19. Subjective and objective screening tests for hydroxychloroquine toxicity.
    Cukras C, Huynh N, Vitale S, Wong WT, Ferris FL, Sieving PA.
    Ophthalmology; 2015 Feb; 122(2):356-66. PubMed ID: 25444344
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.